LadRx Corporation CYTR
0.09 +0.09
Day range unavailable
52-week range unavailable
News
defenseworld.net Sorrento Therapeutics (OTCMKTS:SRNEQ) versus LadRx (OTCMKTS:CYTR) Financial Contrast Profitability This table compares LadRx and Sorrento Therapeutics' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets LadRx N/A -67.61% -45.39% Sorrento…
defenseworld.net Analyzing LadRx (OTCMKTS:CYTR) & SQZ Biotechnologies (NYSE:SQZ) Volatility and Risk SQZ Biotechnologies has a beta of 2.34, indicating that its share price is 134% more volatile than the S&P 500. Comparatively, LadRx has a beta of 1.96, indicating that its share…
defenseworld.net Contrasting Sorrento Therapeutics (OTCMKTS:SRNEQ) and LadRx (OTCMKTS:CYTR) Institutional and Insider Ownership 0.1% of LadRx shares are held by institutional investors. Comparatively, 0.0% of Sorrento Therapeutics shares are held by institutional investors. 12.8% of LadRx…
globenewswire.com LadRx Corporation, Inc. to Present at the Virtual Life Science Investor Forum March 13th Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as…
businesswire.com LadRx Planning NDA Submission under 505(b)(2) for Aldoxorubicin and Other Updates LOS ANGELES--(BUSINESS WIRE)--LadRx Corporation (OTCQB: LADX) (“LadRx” or the “Company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, is…
businesswire.com LadRx and ImmunityBio Mutually Agree to Terminate Aldoxorubicin License LOS ANGELES--(BUSINESS WIRE)--LadRx Corporation (OTCQB: LADX) (“LadRx” or the “Company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, is…
pennystocks.com Best Penny Stocks To Buy? 4 To Watch This Week With Potential Catalysts Penny stocks to watch with upcoming event dates to keep in mind this week The post Best Penny Stocks To Buy? 4 To Watch This Week With Potential Catalysts appeared first on Penny Stocks to Buy,…
businesswire.com CytRx Highlights Orphazyme's Submission of European Marketing Authorisation for Arimoclomol to Treat Niemann-Pick Disease Type C LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and…
benzinga.com Stocks That Hit 52-Week Lows On Monday 
benzinga.com Stocks That Hit 52-Week Lows On Friday 
benzinga.com Stocks That Hit 52-Week Lows On Monday 
benzinga.com Stocks That Hit 52-Week Lows On Tuesday - benzinga.com Stocks That Hit 52-Week Lows On Friday
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018
benzinga.com Stocks Which Set New 52-Week Low Yesterday, Mon., Dec. 3, 2018 - benzinga.com Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018
benzinga.com Stocks Which Set New 52-Week Lows Fri., Nov. 16, 2018 - benzinga.com Stocks Which Set New 52-Week Low Yesterday, October 23rd
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, October 22nd
benzinga.com Stocks Which Set New 52-Week Low Yesterday, October 11th 
benzinga.com Stocks Which Set New 52-Week Low Yesterday, October 10th - benzinga.com Stocks Which Set New 52-Week Low Yesterday, September 19th
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, September 11th
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, August 15th
- benzinga.com 10 Biggest Mid-Day Losers For Friday